Review Functional Specialization of Interleukin-17 Family Members

Interleukin-17A (IL-17A) is the signature cytokine of the recently identified T helper 17 (Th17) cell subset. IL-17 has six family members (IL-17A to IL-17F). Although IL-17A and IL-17F share the highest amino acid sequence homology, they perform distinct functions; IL-17A is involved in the development of autoimmunity, inflammation, and tumors, and also plays important roles in the host defenses against bacterial and fungal infections, whereas IL-17F is mainly involved in mucosal host defense mechanisms. IL-17E (IL-25) is an amplifier of Th2 immune responses. The functions of IL-17B, IL-17C, and IL-17D remain largely elusive. In this review, we describe the identified functions of each IL-17 family member and discuss the potential of these molecules as therapeutic targets.

[1]  G. Ho.  Faculty Opinions recommendation of Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. , 2015 .

[2]  A. Blauvelt,et al.  IL-23–Mediated Psoriasis-Like Epidermal Hyperplasia Is Dependent on IL-17A , 2011, The Journal of Immunology.

[3]  D. Artis,et al.  CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. , 2011, Immunity.

[4]  T. Wynn,et al.  Critical Role of IL-25 in Nematode Infection-Induced Alterations in Intestinal Function , 2010, The Journal of Immunology.

[5]  J. O’Shea,et al.  Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. , 2010, Cytokine & growth factor reviews.

[6]  C. Dong,et al.  IL-17 family member cytokines: regulation and function in innate immunity. , 2010, Cytokine & growth factor reviews.

[7]  P. Teeling,et al.  Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis , 2010, PloS one.

[8]  Yufang Shi,et al.  Modulation of experimental autoimmune encephalomyelitis through TRAF3-mediated suppression of interleukin 17 receptor signaling , 2010, The Journal of experimental medicine.

[9]  D. Artis,et al.  Innate immune cell populations function as initiators and effectors in Th2 cytokine responses. , 2010, Trends in immunology.

[10]  J. Bernstein,et al.  A novel subset of CD4+ TH2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma , 2010, The Journal of experimental medicine.

[11]  Peter W. Chen,et al.  IL-17 Promotes Immune Privilege of Corneal Allografts , 2010, The Journal of Immunology.

[12]  P. Tak,et al.  Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis , 2010, Science Translational Medicine.

[13]  L. Moreland,et al.  Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy , 2010, Drug design, development and therapy.

[14]  V. Kuchroo,et al.  γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. , 2010, Immunity.

[15]  M. Goldman,et al.  Critical Role of Regulatory T Cells in Th17-Mediated Minor Antigen-Disparate Rejection , 2010, The Journal of Immunology.

[16]  K. Venken,et al.  Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens , 2010, Journal of Neuroimmunology.

[17]  A. Valujskikh,et al.  Interleukin-17 promotes early allograft inflammation. , 2010, The American journal of pathology.

[18]  S. Nakae,et al.  TNF, but Not IL-6 and IL-17, Is Crucial for the Development of T Cell-Independent Psoriasis-Like Dermatitis in Il1rn−/− Mice , 2010, The Journal of Immunology.

[19]  C. Tato,et al.  Innate IL-17-producing cells: the sentinels of the immune system , 2010, Nature Reviews Immunology.

[20]  Thomas Korn,et al.  Proinflammatory T helper type 17 cells are effective B-cell helpers , 2010, Proceedings of the National Academy of Sciences.

[21]  D. Xia,et al.  The Overexpression of Heparin-Binding Epidermal Growth Factor Is Responsible for Th17-Induced Airway Remodeling in an Experimental Asthma Model , 2010, The Journal of Immunology.

[22]  W. Ouyang,et al.  IL-17RC Is Required for Immune Signaling via an Extended SEF/IL-17R Signaling Domain in the Cytoplasmic Tail , 2010, The Journal of Immunology.

[23]  J. Sirard,et al.  TLR5 Signaling Stimulates the Innate Production of IL-17 and IL-22 by CD3negCD127+ Immune Cells in Spleen and Mucosa , 2010, The Journal of Immunology.

[24]  Christophe Benoist,et al.  Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. , 2010, Immunity.

[25]  David J. Erle,et al.  Systemically dispersed innate IL-13–expressing cells in type 2 immunity , 2010, Proceedings of the National Academy of Sciences.

[26]  M. Cao,et al.  IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo , 2010, Cancer Immunology, Immunotherapy.

[27]  S. Akira,et al.  Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. , 2010, Immunity.

[28]  J. Kolls.  Faculty Opinions recommendation of IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. , 2010 .

[29]  U. Müller-Ladner,et al.  Actual status of antiinterleukin-1 therapies in rheumatic diseases , 2010, Current opinion in rheumatology.

[30]  M. Wills-Karp,et al.  Complement-mediated Regulation Of The IL-17A Axis Is A Central Genetic Determinant Of The Severity Of Experimental Allergic Asthma , 2010, ATS 2010.

[31]  D. Danilenko,et al.  IL-17RC Is Required for IL-17A– and IL-17F–Dependent Signaling and the Pathogenesis of Experimental Autoimmune Encephalomyelitis , 2010, The Journal of Immunology.

[32]  M. Genovese,et al.  LY2439821, a humanized anti-interleukin-17 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I randomized, double-blind, placebo-controlled, proof-of-concept study. , 2010, Arthritis and rheumatism.

[33]  T. Wynn,et al.  Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent , 2010, The Journal of experimental medicine.

[34]  D. Zelterman,et al.  Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis , 2010, Proceedings of the National Academy of Sciences.

[35]  D. Douek,et al.  Th17 cells, Job's syndrome and HIV: opportunities for bacterial and fungal infections , 2010, Current opinion in HIV and AIDS.

[36]  P. Teeling,et al.  Differential expression of interleukin‐17 family cytokines in intact and complicated human atherosclerotic plaques , 2010, The Journal of pathology.

[37]  A. McKenzie,et al.  Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity , 2010, Nature.

[38]  H. Watarai,et al.  Regulation of IL-9 expression by IL-25 signaling , 2010, Nature Immunology.

[39]  B. Strober,et al.  Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. , 2010, The New England journal of medicine.

[40]  S. Tuske,et al.  Structure of IL-17A in complex with a potent, fully human neutralizing antibody. , 2009, Journal of molecular biology.

[41]  J. Alcorn,et al.  Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. , 2009, Immunity.

[42]  P. Hwu,et al.  T helper 17 cells promote cytotoxic T cell activation in tumor immunity. , 2009, Immunity.

[43]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[44]  P. Schwartzberg,et al.  Differential expression of interleukin-17A and -17F is coupled to T cell receptor signaling via inducible T cell kinase. , 2009, Immunity.

[45]  Annaïg Lan,et al.  The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. , 2009, Immunity.

[46]  R. Geha,et al.  Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. , 2009, The Journal of allergy and clinical immunology.

[47]  P. Duquette,et al.  Preferential recruitment of interferon‐γ–expressing TH17 cells in multiple sclerosis , 2009, Annals of neurology.

[48]  Cynthia L Sears,et al.  A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses , 2009, Nature Medicine.

[49]  P. Muranski,et al.  Type 17 CD8+ T cells display enhanced antitumor immunity. , 2009, Blood.

[50]  W. Zou,et al.  Endogenous IL-17 contributes to reduced tumor growth and metastasis. , 2009, Blood.

[51]  Hua Yu,et al.  IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway , 2009, The Journal of experimental medicine.

[52]  S. Gaffen.  Structure and signalling in the IL-17 receptor family , 2009, Nature Reviews Immunology.

[53]  A. Puisieux,et al.  Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus , 2009, Nature Immunology.

[54]  A. Rizzo,et al.  Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. , 2009, Gastroenterology.

[55]  Richard A Flavell,et al.  A protective function for interleukin 17A in T cell–mediated intestinal inflammation , 2009, Nature Immunology.

[56]  Mohamed El-behi,et al.  IL-23 Drives Pathogenic IL-17-Producing CD8+ T Cells1 , 2009, The Journal of Immunology.

[57]  D. Littman,et al.  Transcriptional regulatory networks in Th17 cell differentiation. , 2009, Current opinion in immunology.

[58]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[59]  Erin E. Murphy,et al.  Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation , 2009, The Journal of experimental medicine.

[60]  A. Shapiro,et al.  Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice , 2009, Diabetes.

[61]  D. Bending,et al.  Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. , 2009, The Journal of clinical investigation.

[62]  S. Gaffen,et al.  Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis , 2009, The Journal of experimental medicine.

[63]  J. Renauld,et al.  Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. , 2009, Arthritis and rheumatism.

[64]  Christopher G. King,et al.  IL-17 contributes to CD4-mediated graft-versus-host disease. , 2009, Blood.

[65]  C. Sasakawa,et al.  Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. , 2009, Immunity.

[66]  C. Elson,et al.  Late developmental plasticity in the T helper 17 lineage. , 2009, Immunity.

[67]  A. Murphy,et al.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. , 2008, Immunity.

[68]  B. Becher,et al.  IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. , 2008, The Journal of clinical investigation.

[69]  T. Okanoue,et al.  Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. , 2008, Biochemical and biophysical research communications.

[70]  Changlong Lu,et al.  Inhibitory Effect of Recombinant IL-25 on the Development of Dextran Sulfate Sodium-Induced Experimental Colitis in Mice , 2008, Cellular and Molecular Immunology.

[71]  S. Nakae,et al.  The roles of IL‐17A in inflammatory immune responses and host defense against pathogens , 2008, Immunological reviews.

[72]  K. T. Holland,et al.  Differential innate immune responses of a living skin equivalent model colonized by Staphylococcus epidermidis or Staphylococcus aureus. , 2008, FEMS microbiology letters.

[73]  M. Taniguchi,et al.  A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity , 2008, The Journal of experimental medicine.

[74]  Zizhen Kang,et al.  SY-16 The critical role of epithelial-derived act1 in IL-17- and IL-25-mediated pulmonary inflammation , 2008 .

[75]  T. Yi,et al.  Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. , 2008, Blood.

[76]  R. Kastelein,et al.  Commensal-dependent expression of IL-25 regulates the IL-23–IL-17 axis in the intestine , 2008, The Journal of experimental medicine.

[77]  C. Constantinescu,et al.  Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study , 2008, The Lancet Neurology.

[78]  L. Joosten,et al.  IL-17 produced by Paneth cells drives TNF-induced shock , 2008, The Journal of experimental medicine.

[79]  J. V. Sarma,et al.  Adverse functions of IL‐17A in experimental sepsis , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[80]  J. Highton,et al.  Different T cell subsets in the nodule and synovial membrane: absence of interleukin-17A in rheumatoid nodules. , 2008, Arthritis and rheumatism.

[81]  A. Kimball,et al.  Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1) , 2008, The Lancet.

[82]  R. Broaddus,et al.  Regulation of inflammatory responses by IL-17F , 2008, The Journal of experimental medicine.

[83]  F. Powrie,et al.  Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis , 2008, Immunity.

[84]  M. McGeachy,et al.  Th17 cell differentiation: the long and winding road. , 2008, Immunity.

[85]  Jay K Kolls,et al.  Simian immunodeficiency virus–induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut , 2008, Nature Medicine.

[86]  M. Fei,et al.  IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia , 2008, Nature Medicine.

[87]  S. Sa,et al.  Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens , 2008, Nature Medicine.

[88]  S. Goya,et al.  Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17 , 2008, The Journal of experimental medicine.

[89]  Chen Dong,et al.  T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. , 2008, Immunity.

[90]  L. Joosten,et al.  Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. , 2008, The Journal of clinical investigation.

[91]  B. Becher,et al.  IL-22 Is Expressed by Th17 Cells in an IL-23-Dependent Fashion, but Not Required for the Development of Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.

[92]  K. Chung,et al.  Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. , 2007, The Journal of allergy and clinical immunology.

[93]  L. Fouser,et al.  An IL-17F/A Heterodimer Protein Is Produced by Mouse Th17 Cells and Induces Airway Neutrophil Recruitment , 2007, The Journal of Immunology.

[94]  N. Tsuno,et al.  IL-17B and IL-17C Are Associated with TNF-α Production and Contribute to the Exacerbation of Inflammatory Arthritis1 , 2007, The Journal of Immunology.

[95]  Scott R. Presnell,et al.  Identification of the IL-17 Receptor Related Molecule IL-17RC as the Receptor for IL-17F , 2007, The Journal of Immunology.

[96]  L. Cosmi,et al.  Phenotypic and functional features of human Th17 cells , 2007, The Journal of experimental medicine.

[97]  J. Ruland,et al.  Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 , 2007, Nature Immunology.

[98]  R. D. Hatton,et al.  IL-17 family cytokines and the expanding diversity of effector T cell lineages. , 2007, Annual review of immunology.

[99]  Satoshi Tanaka,et al.  T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis , 2007, The Journal of experimental medicine.

[100]  T. Mcclanahan,et al.  IL-25 regulates Th17 function in autoimmune inflammation , 2007, The Journal of experimental medicine.

[101]  B. Ryffel,et al.  Interleukin-17 is a negative regulator of established allergic asthma , 2006, The Journal of experimental medicine.

[102]  Y. Kadono,et al.  Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction , 2006, The Journal of experimental medicine.

[103]  Kotaro Suzuki,et al.  IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice. , 2006, The Journal of allergy and clinical immunology.

[104]  R. Hromas,et al.  The IL-17 cytokine family members are inhibitors of human hematopoietic progenitor proliferation. , 2006, Blood.

[105]  S. Nakae,et al.  IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[106]  L. V. von Segesser,et al.  Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[107]  Niamh E Mangan,et al.  Identification of an interleukin (IL)-25–dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion , 2006, The Journal of experimental medicine.

[108]  T. Mcclanahan,et al.  Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract , 2006, The Journal of experimental medicine.

[109]  Ho‐Youn Kim,et al.  Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. , 2005, Molecules and cells.

[110]  W. Seaman.  Faculty Opinions recommendation of A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. , 2005 .

[111]  A. Lindén,et al.  Interleukin-17 family members and inflammation. , 2004, Immunity.

[112]  T. Mcclanahan,et al.  Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.

[113]  S. Nakae,et al.  Suppression of Immune Induction of Collagen-Induced Arthritis in IL-17-Deficient Mice 1 , 2003, The Journal of Immunology.

[114]  T. Moseley,et al.  Interleukin-17 family and IL-17 receptors. , 2003, Cytokine & growth factor reviews.

[115]  M. Lotze,et al.  Interleukin-17 promotes angiogenesis and tumor growth. , 2003, Blood.

[116]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[117]  I. Homma,et al.  Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. , 2002, Immunity.

[118]  R. Hromas,et al.  Cutting Edge: IL-17D, a Novel Member of the IL-17 Family, Stimulates Cytokine Production and Inhibits Hemopoiesis1 , 2002, The Journal of Immunology.

[119]  R. Kelley,et al.  IL‐17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL‐17F, and implications for receptor binding , 2001, The EMBO journal.

[120]  A. Gurney,et al.  IL-17E, a Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1* , 2001, The Journal of Biological Chemistry.

[121]  K Wathen,et al.  A Novel Cytokine Receptor-Ligand Pair , 2000, The Journal of Biological Chemistry.

[122]  A. Gurney,et al.  Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[123]  J. Banchereau,et al.  Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. , 1999, Cancer research.

[124]  P. Miossec,et al.  Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines. , 1998, Journal of immunology.

[125]  I. Forgacs.  GASTROENTEROLOGY , 1988, The Lancet.

[126]  R. Coffman,et al.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.

[127]  古賀 千律子.  Possible pathogenic role of Th17 cells for atopic dermatitis , 2011 .

[128]  W. Zou,et al.  TH17 cells in tumour immunity and immunotherapy , 2011, Nature Reviews Immunology.

[129]  J. Weinberg.  Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial , 2010 .

[130]  L. Cosmi,et al.  Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. , 2010, The Journal of allergy and clinical immunology.

[131]  茂呂 和世.  Innate production of T[H]2 cytokines by adipose tissue-associated c-Kit[+]Sca-1[+] lymphoid cells , 2010 .

[132]  B. Becher,et al.  RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. , 2009, Gastroenterology.

[133]  T. Sécher,et al.  IL-17 Receptor Signaling Is Required to Control Polymicrobial Sepsis 1 , 2009 .

[134]  小椋 英樹,et al.  Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction , 2009 .

[135]  S. Nakae,et al.  IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver. , 2008, Journal of immunology.

[136]  A. Bendele,et al.  Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing gamma delta T cells. , 2007, Journal of immunology.

[137]  Richard J Martin,et al.  IL-23-dependent IL-17 production is essential in neutrophil recruitment and activity in mouse lung defense against respiratory Mycoplasma pneumoniae infection. , 2007, Microbes and infection.

[138]  Hisakata Yamada,et al.  Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. , 2007, Journal of immunology.

[139]  A. Andoh,et al.  Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. , 2004, Clinical immunology.